Kalaris Therapeutics Inc (KLRS) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Kalaris Therapeutics Inc

    NASDAQ: KLRS · Real-Time Price · USD
    6.64
    -0.45 (-6.35%)
    At close: Oct 03, 2025, 3:59 PM
    6.64
    0.00%
    Pre-market: Oct 06, 2025, 04:02 AM EDT

    Kalaris Therapeutics Inc Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q2 2025 Q1 2025 Q3 2024 Q2 2024 Q1 2024 Q4 2023
    Period Ending Jun 30, 2025 Mar 31, 2025 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023
    Revenue
    		 n/a n/a n/a n/a n/a n/a
    Cost of Revenue
    		 n/a n/a n/a n/a n/a n/a
    Gross Profit
    		 n/a n/a n/a n/a n/a n/a
    Operating Income
    		 -12.26M -10.35M -37.85M -4.19M -2.56M -3.46M
    Interest Income
    		 n/a n/a n/a n/a n/a n/a
    Pretax Income
    		 -11.35M -10.2M -38.08M -5.65M -3.41M -3.47M
    Net Income
    		 -11.35M -10.2M -38.08M -5.65M -3.41M -3.47M
    Selling & General & Admin
    		 3.82M 4.32M 1.83M 976K 602K 498K
    Research & Development
    		 8.44M 6.03M 36.02M 3.21M 1.96M 2.97M
    Other Expenses
    		 n/a n/a n/a n/a n/a n/a
    Operating Expenses
    		 12.26M 10.35M 37.85M 4.19M 2.56M 3.46M
    Interest Expense
    		 n/a 1.44M 815K 499K 78K 39K
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a n/a n/a
    Cost & Expenses
    		 12.26M 10.35M 37.85M 4.19M 2.56M 3.46M
    Income Tax Expense
    		 n/a n/a n/a n/a n/a n/a
    Shares Outstanding (Basic)
    		 18.7M 4.05M n/a 18.7M 18.7M n/a
    Shares Outstanding (Diluted)
    		 18.7M 4.05M n/a 18.7M 18.7M n/a
    EPS (Basic)
    		 -0.61 -2.52 n/a -0.3 -0.18 n/a
    EPS (Diluted)
    		 -0.61 -2.52 n/a -0.3 -0.18 n/a
    EBITDA
    		 -11.35M -8.75M -37.27M -5.15M -3.33M -3.43M
    EBIT
    		 -11.35M -8.75M -37.27M -5.15M -3.33M -3.43M
    Depreciation & Amortization
    		 n/a n/a n/a n/a n/a n/a

    Add to Watchlist